Low-throughput systems boost demand for clinical chemistry products
This article was originally published in Clinica
Executive Summary
The clinical chemistry market, worth $5.7bn and forecast to grow at just over 3% per year until 2011, comprises five application segments, including: highthroughput general chemistry analysers and reagents; medium-throughput general chemistry analysers and reagents; low-throughput general chemistry analysers and reagents; critical care analysers; and urine chemistry systems.